Shilpa Medicare Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹349.35
- Today's High:
- ₹368.2
- Open Price:
- ₹366
- 52W Low:
- ₹222.4
- 52W High:
- ₹423.7854
- Prev. Close:
- ₹365.55
- Volume:
- 35078
Company Statistics
- Market Cap.:
- ₹31.60 billion
- Book Value:
- 206.221
- Revenue TTM:
- ₹10.49 billion
- Operating Margin TTM:
- 2.84%
- Gross Profit TTM:
- ₹6.34 billion
- Profit Margin:
- -3.06%
- Return on Assets TTM:
- 0.15%
- Return on Equity TTM:
- -1.72%
Company Profile
Shilpa Medicare Limited had its IPO on under the ticker symbol SHILPAMED.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Shilpa Medicare Limited has a staff strength of 0 employees.
Stock update
Shares of Shilpa Medicare Limited opened at ₹366 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹349.35 - ₹368.2, and closed at ₹352.55.
This is a -3.56% slip from the previous day's closing price.
A total volume of 35,078 shares were traded at the close of the day’s session.
In the last one week, shares of Shilpa Medicare Limited have slipped by -5.47%.
Shilpa Medicare Limited's Key Ratios
Shilpa Medicare Limited has a market cap of ₹31.60 billion, indicating a price to book ratio of 1.4166 and a price to sales ratio of 2.2334.
In the last 12-months Shilpa Medicare Limited’s revenue was ₹10.49 billion with a gross profit of ₹6.34 billion and an EBITDA of ₹1.30 billion. The EBITDA ratio measures Shilpa Medicare Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Shilpa Medicare Limited’s operating margin was 2.84% while its return on assets stood at 0.15% with a return of equity of -1.72%.
In Q2, Shilpa Medicare Limited’s quarterly earnings growth was a positive 40% while revenue growth was a negative 0.4%.
Shilpa Medicare Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹-3.69 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shilpa Medicare Limited’s profitability.
Shilpa Medicare Limited stock is trading at a EV to sales ratio of 2.9041 and a EV to EBITDA ratio of 19.3231. Its price to sales ratio in the trailing 12-months stood at 2.2334.
Shilpa Medicare Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.3% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹29.02 billion
- Total Liabilities
- ₹7.83 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Shilpa Medicare Limited ended 2024 with ₹29.02 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹29.02 billion while shareholder equity stood at ₹17.83 billion.
Shilpa Medicare Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹7.83 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹455.27 million in goodwill. Its cash balance stood at ₹213.18 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹2.89 billion.
Shilpa Medicare Limited’s total current assets stands at ₹7.68 billion while long-term investments were ₹0 and short-term investments were ₹31.73 million. Its net receivables were ₹3.24 billion compared to accounts payable of ₹1.44 billion and inventory worth ₹3.20 billion.
In 2024, Shilpa Medicare Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Shilpa Medicare Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹352.55
- 52-Week High
- ₹423.7854
- 52-Week Low
- ₹222.4
- Analyst Target Price
- ₹
Shilpa Medicare Limited stock is currently trading at ₹352.55 per share. It touched a 52-week high of ₹423.7854 and a 52-week low of ₹423.7854. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹343.05 and 200-day moving average was ₹280.56 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6521.8% of the company’s stock are held by insiders while 294.3% are held by institutions.
Frequently Asked Questions About Shilpa Medicare Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Shilpa Medicare Limited, together with its subsidiaries, engages in the manufacturing and selling active pharmaceutical ingredients (APIs), intermediates, and formulations in India, the United States, Europe, and internationally. It’s primary oncology and non-oncology APIs include capecitabine, gemcitabine hydrochloride, axitinib, erlotinib hydrochloride, and irinotecan hydrochloride, as well as ambroxol, tranexmic acid, and ursodeoxycholic acid; and new drug delivery systems, peptides/biotech products, specialty chemicals, etc. The company also provides contract manufacturing of various dosage forms, such as tablets, capsules, liquid injections, lyophilized injectables, and sterile dry powder injectables. It is also involved in the wind power generation activities. Shilpa Medicare Limited was incorporated in 1987 and is headquartered in Raichur, India.